---
schema_version: "secwatch.filing_event.v1"
accession: "0001722482-24-000142"
form_type: "8-K"
ticker: "AVTR"
cik: "0001722482"
company_name: "Avantor, Inc."
filed_at: "2024-07-26T23:59:59+00:00"
generated_at: "2026-05-31T15:58:47.225092+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Avantor reports Q2 net sales down 2.4% to $1.70B; GAAP EPS $0.14, adjusted $0.25

## Summary
- Net sales $1.70B, down 2.4% YoY; organic decline 2.0% after FX impact.
- Net income $93M vs ($7.3M) loss Q2 2023; GAAP diluted EPS $0.14, adjusted EPS $0.25.
- Adjusted EBITDA $306M (17.9% margin); free cash flow $235M with >100% conversion.
- Lab Solutions sales $1,155.7M (-3.2% reported), Bioscience Production $547.1M (-0.5%).
- Fiscal 2024 guidance reaffirmed; adjusted net leverage 3.9x as of June 30.

## SEC filing metadata
- accession: 0001722482-24-000142
- form_type: 8-K
- ticker: AVTR
- cik: 0001722482
- company_name: Avantor, Inc.
- filed_at: 2024-07-26T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1722482/000172248224000142/0001722482-24-000142-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1722482/000172248224000142/avtr-20240726.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001722482-24-000142
- JSON: https://secwatch.observer/filing/0001722482-24-000142.json
- Plain text: https://secwatch.observer/filing/0001722482-24-000142.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.